| Date Filed | Type | Description |
| 08/17/2023 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 318 shares
@ $66.878, valued at
$21.3k
Sold 5,000 shares
@ $90, valued at
$450k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/17/2023 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 10,110 shares
@ $0
Paid exercise price by delivering 3,971 shares
@ $87.74, valued at
$348.4k
Paid exercise price by delivering 20,510 shares
@ $93.41, valued at
$1.9M
Granted 23,070 options to buy
@ $87.74, valued at
$2M
|
|
| 03/02/2023 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 20,760 shares
@ $0
Granted 10,380 shares
@ $0
Granted 7,629 shares
@ $0 |
|
| 01/27/2023 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 44,825 shares
@ $115.654, valued at
$5.2M
Sold 4,175 shares
@ $116.154, valued at
$484.9k
Exercised 2,200 options to buy
@ $67.81, valued at
$149.2k
Exercised 46,800 options to buy
@ $67.81, valued at
$3.2M
|
|
| 11/04/2022 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 3,000 shares
@ $86.12, valued at
$258.4k
|
|
| 09/26/2022 |
4
| Ajer Jeffrey Robert (Director) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 4,198 shares
@ $3.16, valued at
$13.3k
|
|
| 09/20/2022 |
4
| Ajer Jeffrey Robert (Director) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 10,200 shares
@ $0
Granted 20,400 options
@ $3.47, valued at
$70.8k
|
|
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2022 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 1,180 shares
@ $82.47, valued at
$97.3k
|
|
| 03/31/2022 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 1,618 shares
@ $79.43, valued at
$128.5k
Sold 1,381 shares
@ $79.56, valued at
$109.9k
|
|
| 03/24/2022 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 2,073 shares
@ $81, valued at
$167.9k
Sold 6,129 shares
@ $81.78, valued at
$501.2k
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2021 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 342 shares
@ $62.407, valued at
$21.3k
Sold 2,739 shares
@ $73.6, valued at
$201.6k
|
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2020 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 2,121 shares
@ $79.91, valued at
$169.5k
|
|
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/24/2020 |
4
| Ajer Jeffrey Robert (Director) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 9,100 shares
@ $0
Granted 18,200 options
@ $18.91, valued at
$344.2k
|
|
| 09/21/2020 |
4
| Ajer Jeffrey Robert (Director) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 2,250 shares
@ $19.74, valued at
$44.4k
|
|
| 06/23/2020 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 338 shares
@ $62.586, valued at
$21.2k
Sold 15,000 shares
@ $124, valued at
$1.9M
Exercised 15,000 options to buy
@ $63.1, valued at
$946.5k
|
|
| 04/09/2020 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 2,407 shares
@ $79.98, valued at
$192.5k
|
|
| 04/02/2020 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 1,537 shares
@ $82, valued at
$126k
|
|
| 03/26/2020 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 2,041 shares
@ $74.36, valued at
$151.8k
Sold 1,618 shares
@ $78.47, valued at
$127k
|
|
| 03/24/2020 |
4
| Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 3,599 shares
@ $73.05, valued at
$262.9k
|
|
|